Who has invested in Personal Genome Diagnostics?

Cowen Healthcare Investments, Bristol-Myers Squibb, New Enterprise Associates are named among the investors backing Personal Genome Diagnostics.

Personal Genome Diagnostics Funding: $199M Raised, Series C

Personal Genome Diagnostics funding overview

Personal Genome Diagnostics is based in Burlington, North Carolina. Personal Genome Diagnostics has raised $199M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2021. The round record for Personal Genome Diagnostics runs through 2021; nothing later has been disclosed. Investors on record include Cowen Healthcare Investments, Bristol-Myers Squibb, New Enterprise Associates. 3 distinct backers are named across the disclosed rounds.

Personal Genome Diagnostics at a glance

Total raised: $199M
Latest round: Series C
Latest round date: January 2021
Headquarters: Burlington, North Carolina
Notable investors: Cowen Healthcare Investments, Bristol-Myers Squibb, New Enterprise Associates

Frequently asked about Personal Genome Diagnostics funding

How much has Personal Genome Diagnostics raised?: Personal Genome Diagnostics has raised $199M in total disclosed funding across the rounds on record.
Who has invested in Personal Genome Diagnostics?: Cowen Healthcare Investments, Bristol-Myers Squibb, New Enterprise Associates are named among the investors backing Personal Genome Diagnostics.
What was the latest Personal Genome Diagnostics funding round?: The most recent disclosed round is a Series C, announced in January 2021.
Where is Personal Genome Diagnostics based?: Personal Genome Diagnostics is based in Burlington, North Carolina.
When did Personal Genome Diagnostics last raise?: The last disclosed Personal Genome Diagnostics round closed in January 2021 at Series C.

Round data for Personal Genome Diagnostics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Burlington and backer lists below.

Personal Genome Diagnostics Funding: $199M Raised, Series C

Personal Genome Diagnostics funding overview

Personal Genome Diagnostics at a glance

Frequently asked about Personal Genome Diagnostics funding

Companies related to Personal Genome Diagnostics (36)

Browse related funding lists (5)